FDA Grants Atrovent Nasal Spray Pediatric Indication For Rhinorrhea
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




FDA Grants Atrovent Nasal Spray Pediatric Indication For Rhinorrhea

RIDGEFIELD, CT -- Sept. 1, 1998 -- Boehringer Ingelheim Pharmaceuticals, Inc.’ s Atrovent(R) (ipratropium bromide) Nasal Spray .03% for the treatment of rhinorrhea (runny nose) associated with allergic and nonallergic perennial rhinitis has now been granted and indication for use in children six years and up by the United States Food and Drug Administration.

It is not indicated for the relief of nasal congestion, sneezing or postnasal drip.

Atrovent Nasal Spray .03% is an anticholinergic agent that blocks the action of acetylcholine, which causes a runny nose. It provides significant relief from the first day of therapy, with no nasal rebound.

In clinical trials, the most frequently reported nasal adverse events were transient episodes of epistaxis (9.0 percent versus 4.6 percent with vehicle) or nasal dryness (5.1 percent versus 0.9 percent with vehicle). The most frequently reported non-nasal adverse events were transient episodes of headache (9.8 percent versus 9.2 percent with vehicle) or upper respiratory tract infections (9.8 percent versus 7.2 percent with vehicle).

Related Links: Atrovent, Boehringer Ingelheim Pharmaceuticals, Inc

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities